Flicker sensitivity change predicts development of GA

Article

The rate of change in flicker sensitivities is helpful in predicting geographic atrophy (GA)

The rate of change in flicker sensitivities is helpful in predicting geographic atrophy (GA), according to a study in the Archives of Ophthalmology.

The longitudinal investigation, led by Dr D. Luu, Centre for Eye Research Australia, University of Melbourne, Australia, looked at 187 patients with early age-related macular degeneration (AMD).

Patients completed a minimum of four consecutive 6-monthly flicker perimetry tests. The study groups included 16 people who developed GA, 24 controls and 18 high-risk early-AMD patients.

The results revealed that compared to the control group, mean flicker sensitivity reduced in the months before the patients developed GA or choroidal neovascularization (CNV).

Rate of change in flicker sensitivity significantly increased in GA patients, but not in patients with CNV. Eyes that developed late AMD experienced a large reduction in flicker sensitivity.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.